TrialThe Lancet. Infectious diseases2017

Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study.

Richard J Vickers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.